Home › Funds › HEIGHTS CAPITAL MANAGEMENT, INC › TSHA

HEIGHTS CAPITAL MANAGEMENT, INC position in TSHA

TAYSHA GENE THERAPIES INC · Health Care

HEIGHTS CAPITAL MANAGEMENT, INC reported holding 1,375,760 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q3 2026 13F filing — a position valued at US$6.7M, representing 1.66% of its reported portfolio and ranking #8 among its reported holdings. HEIGHTS CAPITAL MANAGEMENT, INC has disclosed TSHA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.38M sh
Reported value held$6.70M
Portfolio Weight1.66%
First reportedQ2 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How HEIGHTS CAPITAL MANAGEMENT, INC's TSHA position evolved

HEIGHTS CAPITAL MANAGEMENT, INC first disclosed a stake in TSHA in Q2 2026 at 1,500,000 shares (US$10.2M). Across 2 filings, HEIGHTS CAPITAL MANAGEMENT, INC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,375,760 shares valued at US$6.7M — a reduction of -124,240 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.50M $10.21M New
Q3 2026 1.38M $6.70M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TSHA and 13F data

TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 46 other funds we track also report a position in TSHA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$148.2M), Avoro Capital Advisors LLC (US$116.3M), Vestal Point Capital, LP (US$87.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TSHA

All TSHA fund holders →

FAQ

How long has HEIGHTS CAPITAL MANAGEMENT, INC held TSHA?

HEIGHTS CAPITAL MANAGEMENT, INC has disclosed TSHA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is HEIGHTS CAPITAL MANAGEMENT, INC's current position in TSHA?

As of Q3 2026, HEIGHTS CAPITAL MANAGEMENT, INC holds 1.38M shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $6.70M, representing 1.66% of its reported portfolio and ranking #8.

Has HEIGHTS CAPITAL MANAGEMENT, INC been buying or selling TSHA?

In the latest 13F filing (Q3 2026), HEIGHTS CAPITAL MANAGEMENT, INC reduced its position in TSHA.

Which other funds hold TSHA?

Other major institutional holders of TSHA include RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, Vestal Point Capital, LP, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.